| Literature DB >> 34067295 |
Shirin Pourafshar1, Mira Nicchitta2,3,4, Crystal C Tyson3, Laura P Svetkey3,5, David L Corcoran6, James R Bain3,5, Michael J Muehlbauer5, Olga Ilkayeva3,5, Thomas M O'Connell5,7, Pao-Hwa Lin3,5, Julia J Scialla1,3,8.
Abstract
We aimed to identify plasma and urine metabolites altered by the Dietary Approaches to Stop Hypertension (DASH) diet in a post-hoc analysis of a pilot feeding trial. Twenty adult participants with un-medicated hypertension consumed a Control diet for one week followed by 2 weeks of random assignment to either Control or DASH diet. Non-missing fasting plasma (n = 56) and 24-h urine (n = 40) were used to profile metabolites using untargeted gas chromatography/mass spectrometry. Linear models were used to compare metabolite levels between the groups. In urine, 19 identifiable untargeted metabolites differed between groups at p < 0.05. These included a variety of phenolic acids and their microbial metabolites that were higher during the DASH diet, with many at false discovery rate (FDR) adjusted p < 0.2. In plasma, eight identifiable untargeted metabolites were different at p < 0.05, but only gamma-tocopherol was significantly lower on DASH at FDR adjusted p < 0.2. The results provide insights into the mechanisms of benefit of the DASH diet.Entities:
Keywords: DASH; blood pressure; metabolomics; nutrition; polyphenols
Year: 2021 PMID: 34067295 DOI: 10.3390/nu13061768
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717